SCHEMBL17448809

SCHEMBL17448809

CC1=C(CCCCCCCCC=O)C(C)(C)CCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 2/20 0.41
RARG P13631 2/20 0.41
RARA P10276 1/20 0.41
RXRA P19793 1/20 0.41
ALDH1A1 P00352 3/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALOX15 P16050 2/20 0.38
ALOX5 P09917 1/20 0.38
TRPA1 O75762 5/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CYP1A2 P05177 1/20 0.36
LMNA P02545 1/20 0.34
HAO1 Q9UJM8 1/20 0.34
PLA2G1B P04054 1/20 0.34
PLA2G2A P14555 1/20 0.34
POLK Q9UBT6 1/20 0.34
TSHR P16473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9273110 0.98 RARB (0.42) RARBRARGRARARXRAALDH1A1
SCHEMBL3156466 0.94 RARB (0.43) RARBRARGRARARXRAALDH1A1
SCHEMBL9271635 0.87 RARB (0.45) RARBRARGRARARXRAALDH1A1
SCHEMBL7017316 0.79 ALDH1A1 (0.45) RARBRARGRARARXRAALDH1A1
SCHEMBL7185668 0.79 ALDH1A1 (0.45) RARBRARGRARARXRAALDH1A1
SCHEMBL9266425 0.79 ALDH1A1 (0.45) RARBRARGRARARXRAALDH1A1
SCHEMBL29965248 0.79 ALDH1A1 (0.45) RARBRARGRARARXRAALDH1A1
SCHEMBL11492167 0.78 ALDH1A1 (0.43) RARBRARGRARARXRAALDH1A1
SCHEMBL9213310 0.78 RARB (0.39) RARBRARGRARARXRAALDH1A1
SCHEMBL25220580 0.77 TRPA1 (0.37) MAPTALOX15TRPA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160015656-A2 COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE NITTO DENKO CORPORATION (JP) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160015656-A2 COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE COL1A1, COL2A1, COL14A1 RARB 593/4885RARG 812/4885RARA 1080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.